OBSTETRIC COMPLICATIONS IN DIFFERENT FORMS OF HYPERTENSION IN PREGNANT WOMEN


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To assess the relationship of genetic and acquired risk factors and hemostatic status to complicated pregnancy in different forms of hypertension. Design. A prospective cohort study. Methods. Clinical, coagulation, molecular genetic, immunological, and statistical studies. Subject. These included 106 women with chronic hypertension, 21 with chronic hypertension concurrent with preeclampsia, 63 with gestational hypertension, 10 with preeclampsia, and 100 nonhypertensive women who had no family history of obstetric/gynecological and/or thrombotic diseases. Results. Overweight, obesity, and smoking were most common in the pregnant women with all forms of hypertension and the women with chronic hypertension and preeclampsia had also more frequently a family history of hypertension and venous and arterial thrombosis than the nonhypertensive pregnant women. Pregnancy was more often complicated by chronic placental insufficiency and fetal growth restriction in the women with all forms of hypertension. The outcomes of pregnancy were characterized by higher preterm birth rates and lower neonatal weight for height indicators in the chronic hypertension + preeclampsia group than in the nonhypertension one. Evaluation of hemostatic status in the women with hypertension concurrent with preeclampsia showed excessive activation of the platelet and coagulation components of hemostasis throughout their pregnancy as compared to the nonhypertensive women. The women with chronic hypertension were found to have a higher frequency of the D allele and DD genotype in the angiotensin-converting enzyme gene, the C allele in the angiotensinogen II type-1 receptor gene, the T allele and CT genotype in the MTHFR gene, as well as the T allele and TC genotype in the NO synthase gene than the nonhypertensive women. The pregnant women with preeclampsia were observed to have a higher frequency of the M allele and MM genotype in the angiotensinogen T174M gene. The factors independently associated with hypertension during pregnancy were an increased Quetelet index (>25 kg/m 2), TM genotype in the angiotensin-II gene, and the AC genotype in the angiotensin II type-1 receptor gene. Conclusion. Identification of genetic and clinical predictors makes it possible to improve the prediction of different forms of hypertension during pregnancy and to timely form risk groups to prevent hypertension-associated gestational complications.

Full Text

Restricted Access

About the authors

V. F DOLGUSHINA

South Ural State Medical University, Ministry of Health of the Russian Federation

Chelyabinsk

V. S CHULKOV

South Ural State Medical University, Ministry of Health of the Russian Federation

Email: vschulkov@rambler.ru
Chelyabinsk

N. K VEREINA

South Ural State Medical University, Ministry of Health of the Russian Federation

Chelyabinsk

S. P SINITSYN

South Ural State Medical University, Ministry of Health of the Russian Federation

Chelyabinsk

References

  1. Гипертензия во время беременности. Преэклампсия. Эклампсия. Клинический протокол. М.: ФГБУ «НЦ АГиП им. акад. Кулакова»; Минздравсоцразвития России; Институт Здоровья семьи; Проект «Мать и дитя»; 2012. 44 с.
  2. Диагностика и лечение сердечно-сосудистых заболеваний при беременности. Национальные рекомендации. М.: Всероссийское научное общество кардиологов; 2010. 40 с.
  3. Макаров О.В., Волкова Е.В., Пониманская М.А. Патогенетические аспекты артериальной гипертензии. Лечебное дело. 2011; 1: 49-55.
  4. Ткачева О.Н., Рунихина Н.К. Артериальная гипертензия у беременных. Антагонисты кальция. М.: ИД МЕДПРАКТИКА; 2010. 148 с.
  5. Синицын С.П., Чулков В.С., Вереина Н.К. Артериальная гипертензия у беременных с факторами тромбогенного риска: особенности течения различных клинических форм, состояния органов-мишеней и показателей гемостаза. Артериальная гипертензия. 2009; 15(5): 580-4.
  6. Сидорова И.С., Никитина Н.А., Унанян А.Л., Рзаева А.А., Кинякин В.В. Патогенетическое обоснование дифференцированного подхода к ведению беременных с артериальной гипертензией и преэклампсией. Акушерство и гинекология. 2013; 2: 35-40.
  7. Leeners B., Rath W., Kuse S., Irawan C., Imthurn B., Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin. Sci. (London). 2006; 111: 81-6.
  8. Nakayama T., Yamamoto T. Comparison between essential hypertension and pregnancy-induced hypertension: a genetic perspective. Endocr. J. 2009; 56(8): 921-34.
  9. Сухих Г.Т., Вихляева Е.М., Ванько Л.В., Ходжаева З.С., Шуршалина А.В., Холин А.М. Эндотелиальная дисфункция и генез перинатальной патологии. Акушерство и гинекология. 2008; 5: 3-7.
  10. Кирющенков П.А. Физиология системы гемостаза и ее особенности при неосложненной беременности. Эффективная фармакотерапия в акушерстве и гинекологии. 2010; 4: 16-20.
  11. Трифонова Е.А., Габидулина Т.В., Агаркова Т.А., Габитова Н.А., Степанов В.А. Гомоцистеин, полиморфизмы гена MTHFR и осложнения беременности. Акушерство и гинекология. 2011; 2: 8—13.
  12. Вереина Н.К., Синицын С.П., Чулков В.С. Динамика показателей гемостаза при физиологически протекающей беременности. Клиническая лабораторная диагностика. 2012; 2: 43-5.
  13. Чулков В.С., Синицын С.П., Вереина Н.К. Течение беременности и родов, показатели гемостаза у женщин с избыточной массой тела и ожирением. Акушерство и гинекология. 2011; 1: 22—6.
  14. Макацария А.Д., Пшеничникова Е.Б., Пшеничникова Т.Б., Бицадзе В.О. Метаболический синдром и тромбофилия в акушерстве и гинекологии. М.: МИА; 2006. 480 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies